Bevacizumab in age-related macular degeneration: a randomized controlled trial on the effect of injections every 4 weeks, 6 weeks and 8 weeks
- Tanya Lushchyk
- , Sankha Amarakoon
- , José P Martinez-Ciriano
- , L Ingeborgh van den Born
- , G Seerp Baarsma
- , Tom Missotten
Research output: Contribution to journal › Article › Research › peer-review